within Pharmacolibrary.Drugs.ATC.N;

model N02AA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 9.666666666666667e-06,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00265,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AA11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxymorphone is a potent semi-synthetic opioid analgesic used for the management of moderate to severe pain. It acts primarily as a mu-opioid receptor agonist and is available in both immediate-release and extended-release oral formulations, as well as parenteral forms. Oxymorphone is approved for clinical use but is a controlled substance due to its abuse potential.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects (both males and females), under fasting conditions, following a single oral immediate-release dose.</p><h4>References</h4><ol><li><p>Guay, DR (2007). Use of oral oxymorphone in the elderly. <i>The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</i> 22(5) 417–430. DOI:<a href=&quot;https://doi.org/10.4140/tcp.n.2007.417&quot;>10.4140/tcp.n.2007.417</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17658959/&quot;>https://pubmed.ncbi.nlm.nih.gov/17658959</a></p></li><li><p> (2007). Oral oxymorphone (Opana). <i>The Medical letter on drugs and therapeutics</i> 49(1251) 3–4. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17179898/&quot;>https://pubmed.ncbi.nlm.nih.gov/17179898</a></p></li><li><p>Matsumoto, AK (2007). Oral extended-release oxymorphone: a new choice for chronic pain relief. <i>Expert opinion on pharmacotherapy</i> 8(10) 1515–1527. DOI:<a href=&quot;https://doi.org/10.1517/14656566.8.10.1515&quot;>10.1517/14656566.8.10.1515</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17661733/&quot;>https://pubmed.ncbi.nlm.nih.gov/17661733</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AA11;
